The phenotype of CSP-specific CD8 T cells was further characterized by the expression of CD44, CD69, and KLGR1 to better differentiate between the main subsets of CSP-specific cells.
These DLBCLs are further characterized by the expression of immunoglobulin light chain kappa or lambda, plasma cell associated antigens CD38 and CD138, and epithelial membrane antigen (EMA), but lack expression of CD30 antigen and many other B- and T-cell markers [4], [6], [7].
In addition, progression of the tumors is further characterized by the expression of D cyclins and CDK4/6, which allow for continued cell division.
The endothelial phenotype of these expanded EPCs was further characterized by the expression of endothelial markers such as von willebrand factor, CD31, and VEGFR2.
STEC from patients were further characterized by the expression of the O157 lipopolysaccharide antigen and enterohemolysin gene (hlyA) by using latex particle agglutination kit (Oxoid Limited, Basingstoke, UK) and PCR, respectively.
Treg are further characterized by the expression of glucocorticoid-induced TNF-receptor-related-protein (GITR), lymphocyte activation gene-3 (LAG-3), and cytotoxic T-lymphocyte-associated antigen 4 (CTLA4).
